Published on December 10th, 2018 | by business-sweden0
Join Swiss Nordic Bio 2019 in Zurich on 7 Feb
Key note by Göran Ando, former Chairman of the Board at Novo Nordisk A/S and currently Senior Advisor at EW Healthcare Partners
On the panel this year:
– Jürg Zürcher, Partner & Biotech/Medtech Leader GSA, Ernst & Young
– Viktor Drvota, CEO, Karolinska Development
– Ingrid Teigland Akay, MD MBA, Founder & Managing Partner, Hadean Ventures
and moderator Anders Härfstrand, Board Member at Karolinska Development & Senior Commercial Advisor at HBM Partners AG.
more panelists TBC in the coming days….
Participants line-up this year, among others, include:
- Seventure Partners, Karolinska Development AB, Industrifonden, Prediktor Medical AS, Capital Rewards Partners, Creathor Venture Management GmbH, Nordic Nanovector, Ysios Capital Partners SGEIC, S.A, Global Core Medical B.V., Bay City Capital, XOventure GmbH, Vifor Pharma AG, Versantis, Ernst & Young Ltd., Novo Ventures
Stay tuned and REGISTER at www.swissnordicbio.com
WHY SWISS NORDIC BIO?
- Exclusive event with High ratio of investors and pharma to biotech/medtech companies and maximum 200 participants in total where all participants are screened before being granted access to the conference
- Hear the latest talk and opinions from leading industry experts at the Investor and Partnering Panel Discussions
- Possibility to pitch and get input on your product & business model from leading investors & pharma and industry peers
- Discuss your product, business model, and possible collaborations in 1-to-1 meetings with investors & pharma as well as industry peers
- Learn more about the possibilities for R&D collaboration between SME, large corporations and academia directly from EUREKA-Eurostars decision makers